✦ LIBER ✦

Ifosfamide with and without Adriamycin in advanced uterine leiomyosarcoma

✍ Scribed by Robert E. Hawkins; Eve Wiltshaw; Janine L. Mansi

Publisher: Springer
Year: 1990
Tongue: English
Weight: 995 KB
Volume: 26
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00685412

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide plus mesna with and without a

Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma

✍ E. Wiltshaw; G. Westbury; C. Harmer; A. McKinna; C. Fisher 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 263 KB

A randomized study of adriamycin with an

A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas

✍ G. A. Omura; F. J. Major; J. A. Blessing; T. V. Sedlacek; J. T. Thigpen; W. T. C 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

Various drug combinations including Adriamycin have been tested in soft tissue sarcomas, but optimal treatment remains unclear. We have evaluated Adriamycin with and without dimethyl-triazeno-imidazole-carboxamide (DTIC) in the treatment of Stage III or IV and recurrent sarcomas of the uterus. Two h

Ambulatory continuous infusion ifosfamid

Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas

✍ Keith M. Skubitz; Hind Hamdan; Roby C. Thompson Jr. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 750 KB

Adriamycin, CCNU, and 5-fluorouracil in

Adriamycin, CCNU, and 5-fluorouracil in patients with advanced gastrointestinal cancer

✍ Bjöurn J. Cedermark; Peter Cunven; Gary Hammarberg 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

## Abstract Forty‐one patients with measurable advanced gastrointestinal malignancy were treated with a combination of Adriamycin (doxorubicin), 5‐FU (5‐fluorouracil), and CCNU (1‐(2‐chloroethyl)‐3‐cyclohexyl‐1‐nitrosourea). The response to therapy was evaluated every eight weeks. In addition to st

Comparative trial of low-dose adriamycin

Comparative trial of low-dose adriamycin plus cyclophosphamide with or without additive hormonal therapy in advanced breast cancer

✍ Richard E. Lloyd; Stephen E. Jones; Sydney E. Salmon 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

Prognostic factors and survival in 1396

Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas : Emphasis on impact of lymphadenectomy and oophorectomy

✍ Daniel S. Kapp; Jacob Y. Shin; John K. Chan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

## Abstract ## BACKGROUND The objectives of the current study were to determine the prognostic factors associated with disease‐specific survival (DSS) and to analyze the role of lymphadenectomy (LND) and oophorectomy in the management of uterine leiomyosarcomas (LMS). ## METHODS Data were abstra